Evidence map›Paper›PMID 34748789›Full record

ReviewNeurotoxicology2022

Mitochondrial iron metabolism and neurodegenerative diseases.

Ruiying Cheng, Varun V Dhorajia, Jonghan Kim, Yuho Kim

Open access · greenAbstract readReview
In one paragraph

Review in Neurotoxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 3 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 3 syntheses or guidelines pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Iron dysregulation in the central nervous system: implications for autism spectrum disorder.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  5. Article
  6. Review
  7. PMiScience · 2026
    Review
  8. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Molecularly Engineered Phenoxazinone-Skeleton Cascade-Activated NIR Probes for Monitoring FeAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  15. Review
  16. Article
  17. Overview of Ferroptosis in Cadmium Toxicity.Biological trace element research · 2026
    Review
  18. Review
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ruiying ChengDepartment of Biomedical and Nutritional Sciences, University of Massachusetts Lowell, USA.
Varun V DhorajiaThe UMass Biomedical Engineering and Biotechnology, USA.
Jonghan KimDepartment of Biomedical and Nutritional Sciences, University of Massachusetts Lowell, USA. Electronic address: jonghan_kim@uml.edu.
Yuho KimDepartment of Physical Therapy and Kinesiology, University of Massachusetts Lowell, USA. Electronic address: yuho_kim@uml.edu.
University of Massachusetts Lowell · USUMass Memorial Health Care · US

Funding

Nanochelation Therapies for Iron Overload DisordersR01HL143020 · NHLBI · UNIVERSITY OF MASSACHUSETTS LOWELL · PI CHOI, HAK SOO, KIM, JONGHAN · 2018 to 2021
$2.6M
Intranasal gene delivery for Alzheimer’s diseaseR21AG074472 · NIA · UNIVERSITY OF MASSACHUSETTS LOWELL · PI AMIJI, MANSOOR M., KIM, JONGHAN · 2021 to 2021
$445k
NHLBI NIH HHS R01 HL143020NIA NIH HHS R21 AG074472
6 · The paper itself

Abstract

Iron is a key element for mitochondrial function and homeostasis, which is also crucial for maintaining the neuronal system, but too much iron promotes oxidative stress. A large body of evidence has indicated that abnormal iron accumulation in the brain is associated with various neurodegenerative diseases such as Huntington's disease, Alzheimer's disease, Parkinson's disease, and Friedreich's ataxia. However, it is still unclear how irregular iron status contributes to the development of neuronal disorders. Hence, the current review provides an update on the causal effects of iron overload in the development and progression of neurodegenerative diseases and discusses important roles of mitochondrial iron homeostasis in these disease conditions. Furthermore, this review discusses potential therapeutic targets for the treatments of iron overload-linked neurodegenerative diseases.

Indexed as

AnimalsHumansIronMitochondriaNeurodegenerative DiseasesIronBrain ironIron overloadIron transportMitochondriaNeuron

Identifiers

PMID34748789
PMCPMC8748425
OpenAlexW3212959806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.